(Q33938797)

30 July 2017

title

The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV. (English)

1 reference

30 July 2017

0 references

Ronald J Ellis

10

0 references

Igor Grant

series ordinal

11

object named as

Igor Grant

1 reference

30 July 2017

7

Susan Morgello

1 reference

30 July 2017

14

CHARTER Group

1 reference

30 July 2017

12

Scott L Letendre

1 reference

30 July 2017

4

Shruti H Mehta

1 reference

30 July 2017

5

Christina M Marra

1 reference

30 July 2017

9

Benjamin B Gelman

1 reference

30 July 2017

13

Justin C McArthur

1 reference

30 July 2017

2

Rosa M Crum

1 reference

30 July 2017

3

Glenn J Treisman

1 reference

30 July 2017

Edward R Hammond

1

1 reference

30 July 2017

David B Clifford

series ordinal

6

1 reference

30 July 2017

David M Simpson

series ordinal

8

1 reference

30 July 2017

language of work or name

English

0 references

publication date

24 June 2014

1 reference

American Journal of Epidemiology

30 July 2017

published in

1 reference

30 July 2017

volume

180

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

297-307

1 reference

Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

A screening algorithm for HIV-associated neurocognitive disorders

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Cognitive neuropsychology of HIV-associated neurocognitive disorders

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Review: a gentle introduction to imputation of missing values

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

HIV dementia: an evolving disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Detoxification systems, passive and specific transport for drugs at the blood-CSF barrier in normal and pathological situations.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

The impact of HIV-associated neuropsychological impairment on everyday functioning

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Presentation of multivariate data for clinical use: The Framingham Study risk score functions

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AAC

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

The meaning and use of the area under a receiver operating characteristic (ROC) curve

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Predictive value of statistical models

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression.

5 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU098

The prevalence and incidence of neurocognitive impairment in the HAART era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU098

Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU098

Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU098

Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU098

HIV-1 infection and cognitive impairment in the cART era: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU098

Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU098

Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU098

Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU098

Prognosis and prognostic research: Developing a prognostic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU098

Selection of important variables and determination of functional form for continuous predictors in multivariable model building

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU098

Ethnicity, race, and gender. Differences in serious adverse events among participants in an antiretroviral initiation trial: results of CPCRA 058 (FIRST Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWU098

Neurologic complications of HIV disease and their treatment

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Racial/ethnic disparities in diagnoses of HIV/AIDS--33 states, 2001-2004.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents, January 28, 2000 by the Panel on Clinical Practices for Treatment of HIV Infection.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4108039

HIV-associated cognitive impairment before and after the advent of combination therapy

29 October 2018

1 reference

12 December 2020

Association of resolution of major depression with increased natural killer cell activity among HIV-seropositive women

1 reference

12 December 2020

Prognosis and prognostic research: what, why, and how?

1 reference

12 December 2020

Detectable cerebrospinal fluid HIV RNA with associated neurological deficits, despite suppression of HIV replication in the plasma compartment

1 reference

12 December 2020

Common and specific dimensions of self-reported anxiety and depression: the BDI-II versus the BDI-IA

1 reference

12 December 2020

Identifiers

DOI

10.1093/AJE/KWU098

1 reference

30 July 2017

1 reference

30 July 2017

1 reference